©The Author(s) 2004.
World J Gastroenterol. Apr 15, 2004; 10(8): 1132-1136
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1132
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1132
Table 1 Experimental groups and concentrations of drugs
| Groups | Names and concentrations of drugs |
| I | RPMI1640 |
| II | L-OHP 4 µg/mL |
| IIIa | rhGH 50 ng/mL |
| IIIb | rhGH 100 ng/mL |
| IIIc | rhGH 200 ng/mL |
| IIId | rhGH 400 ng/mL |
| IVa | rhGH 50 ng/mL + L-OHP 4 µg/mL |
| IVb | rhGH 100 ng/mL + L-OHP 4 µg/mL |
| IVc | rhGH 200 ng/mL + L-OHP 4 µg/mL |
| IVd | rhGH 400 ng/mL + L-OHP 4 µg/mL |
-
Citation: Chen JY, Liang DM, Gan P, Zhang Y, Lin J.
In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells. World J Gastroenterol 2004; 10(8): 1132-1136 - URL: https://www.wjgnet.com/1007-9327/full/v10/i8/1132.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i8.1132